Cardiometabolic, Cardiovascular Complications Less Likely With Hydroxychloroquine in DLE
WEDNESDAY, June 3, 2026-- Hydroxychloroquine (HCQ) treatment for discoid lupus erythematosus (DLE) is associated with a lower risk for developing cardiovascular and cardiometabolic complications, according to a study published online April 17 in...
Read more »
Pharmaceutical news
Monthly News Roundup - May 2026
Influenza Vaccine Effective for Children Aged 2 to 5 Years
Tezepelumab Reduces Need for Oral Corticosteroids in Adults With Asthma
Millions on Medicaid May Soon Have To Prove They’re Working To Keep Coverage
ASCO: Modest Accuracy Seen for Existing Breast Cancer Risk Prediction Models
ASCO: App-Facilitated Palliative Care Improves HRQOL in Advanced Cancer
Mailed FIT Kits Boost Colorectal Cancer Screening Across Racial, Ethnic Groups
Diagnostic Interviews May Not Be Reliable for Behavioral Health Diagnoses
Just 90 Minutes Of Strength Training A Week Linked To Longer Life
Urine Test Can Detect Autism, Study Says
High-Puff Vapes Become More Toxic Over Time, Study Says
Chemo-Free Drug, Tecvayli, Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
Chemo-Free Drug Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30%
